Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Changes include new information about risks associated with Tivicay during pregnancy and a removal of older drugs owing to toxicities.
In particular, having a high hep B viral load increases the risk of women with HIV transmitting the latter virus to their newborns.
Women in a global study began an HIV treatment regimen based on one of the two drugs after 20 weeks of gestation.
Tivicay was associated with a higher rate of viral suppression at delivery compared with Sustiva.
Chinese scientist claims to have edited embryos to make children HIV resistant.
A pair of twin girls have been born as a part of his efforts, greatly alarming the worldwide research community.
Researchers analyzed the immunological mechanisms that may drive this difference.
Preterm delivery is defined as giving birth before 37 weeks of gestation.
A recent clinical trial polled HIV-positive participants about their desire to have children.
The CDC has conducted its first-ever analysis comparing sexual risk behaviors among such subgroups of high school students.
Baby boomers still make up the largest bloc of those with the virus, but youths’ injection drug use is sending their infection rates upward.
Researchers argue that among children born to mothers with HIV, other factors such as the virus and substance use prompt such outcomes.
A review of recent studies found that some antiretrovirals were associated with preterm birth and low birth weight.
A new study found such young people typically hit standard adult milestones but often experience serious life challenges.
A large ongoing study in Botswana has found that about 1 in 150 babies exposed to Tivicay at conception developed such birth defects.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.